Clinical

Latest News

May 10th 2012

By John V. Cox, DO, MBA, FACP, A. Mark Fendrick, MD

Journal of Oncology Practice (JOP) and The American Journal of Managed Care (AJMC) join efforts to highlight work focusing on issues affecting payers and providers.

May 7th 2012

Clinical and Humanistic Aspects of Growth Hormone Deficiency and Growth-Related Disorders

By Alan D. Rogol, MD, PhD

April 11th 2012

CMS Posts Stage 2 Clinical Quality Measures

March 9th 2012

Dr. Bimal Patel Discusses the Rising Costs of Generic Drugs

February 15th 2012

Study: Last Patients on ICU Rounds Get Least Time

Latest Videos

Is a Single-Payer System the Answer to Our Healthcare Woes?

Impact of Consolidation on the Value of Care Delivery

Limitations of ICER's Value Assessment Framework Tool

Evidence Blocks: Patient Versus Societal Costs

The ASCO Value Framework as a Tool for Shared Decision Making

Using the DrugAbacus Value Calculator

The NCCN Evidence Blocks

Can Oncologists Perceive the Value of a Treatment?

Filling the Data Gaps, Improving Patient Understanding

Data Fragmentation: A Barrier to Value Constructs

More News

Celltrion Presents More Data Showing Comparable Efficacy, Safety of Subcutaneous CT-P13 to IV Form

ByAllison Inserro

January 1st 2000

Korean drug maker Celltrion Healthcare recently presented new findings from a 2-part study at the Annual European Congress of Rheumatology 2019 meeting about subcutaneous biosimilar CT-P13 (Inflectra, Remsima).